SCHEMBL7097856

SCHEMBL7097856

CC(=O)OC(/C=C/c1ccccc1)OC(C)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.52
GLA P06280 1/20 0.52
CYP1A2 P05177 2/20 0.50
KMT2A Q03164 1/20 0.46
ALDH1A1 P00352 2/20 0.45
HDAC3 O15379 2/20 0.45
HDAC4 P56524 2/20 0.45
HDAC1 Q13547 2/20 0.45
HDAC2 Q92769 2/20 0.45
HDAC8 Q9BY41 2/20 0.45
HDAC6 Q9UBN7 2/20 0.45
PLIN1 O60240 2/20 0.45
LMNA P02545 2/20 0.45
MAPT P10636 2/20 0.45
RECQL P46063 2/20 0.45
PLIN5 Q00G26 2/20 0.45
ABHD5 Q8WTS1 2/20 0.45
TNKS O95271 1/20 0.45
HCAR2 Q8TDS4 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1199677 1.00 TDP1 (0.52) TDP1GLACYP1A2KMT2AALDH1A1
Hydrochloric Acid SCHEMBL6743369 0.98 TDP1 (0.50) TDP1GLACYP1A2KMT2AALDH1A1
SCHEMBL2782387 0.91 TDP1 (0.47) TDP1GLACYP1A2KMT2AALDH1A1
SCHEMBL7028151 0.85 TDP1 (0.48) TDP1GLACYP1A2KMT2AALDH1A1
SCHEMBL7017483 0.85 TDP1 (0.48) TDP1GLACYP1A2KMT2AALDH1A1
SCHEMBL7022280 0.85 TDP1 (0.48) TDP1GLACYP1A2KMT2AALDH1A1
SCHEMBL12738779 0.85 TDP1 (0.48) TDP1GLACYP1A2KMT2AALDH1A1
SCHEMBL1039974 0.85 TDP1 (0.48) TDP1GLACYP1A2KMT2AALDH1A1
SCHEMBL7026181 0.85 TDP1 (0.48) TDP1GLACYP1A2KMT2AALDH1A1
SCHEMBL7022285 0.85 TDP1 (0.48) TDP1GLACYP1A2KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0977742-B1 THE PREPARATION OF ENANTIOMERICALLY ENRICHED OXAZOLONES AND ALPHA, ALPHA-DISUBSTITUTED AMINO ACIDS UNIV LELAND STANFORD JUNIOR (US) 2003-09-10 EP claimed
US-6130337-A ALKYLATING AN ALLYLIC ELECTROPHILE WITH A 5-OXAZOLONE IN PRESENCE OF A BASE BOARD OF TRUSTEES OF LELAND STANFORD JUNIOR UNIVERSITY (US) 2000-10-10 US claimed
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed
US-6130337-A ALKYLATING AN ALLYLIC ELECTROPHILE WITH A 5-OXAZOLONE IN PRESENCE OF A BASE BOARD OF TRUSTEES OF LELAND STANFORD JUNIOR UNIVERSITY (US) 2000-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 TDP1 1635/4885GLA 2823/4885CYP1A2 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.